Literature DB >> 12740346

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

B Angermayr1, M Cejna, F Karnel, M Gschwantler, F Koenig, J Pidlich, H Mendel, L Pichler, M Wichlas, A Kreil, M Schmid, A Ferlitsch, E Lipinski, H Brunner, J Lammer, P Ferenci, A Gangl, M Peck-Radosavljevic.   

Abstract

BACKGROUND: In patients undergoing transjugular intrahepatic portosystemic shunt (TIPS), prognostic scores may identify those with a poor prognosis or even those with a clear survival benefit. The Child-Pugh score (CPS) is well established but several drawbacks have led to development of the model of end stage liver disease (MELD). AIM: The aim of the study was to compare the predictive power of CPS and MELD, to validate the original MELD formula, and to assess the predictive value of the determinants used in the two prognostic scores outside of a study setting. PATIENTS: A total of 501 patients underwent elective TIPS placement and 475 patients fulfilled the inclusion criteria.
METHODS: Data of all patients undergoing elective TIPS in one university hospital and four community hospitals in Vienna, Austria, between 1991 and 2001, were analysed retrospectively. The main statistical tests were Cox proportional hazards regression model, the log rank test, Kaplan-Meier analysis, and concordance c statistics.
RESULTS: Median follow up was 5.2 years and median survival was 4.6 years. During follow up, 230 patients died, 75 within three months after TIPS placement. In stepwise proportional hazards analyses, independent predictors of death were creatinine level, bilirubin level, age, and refractory ascites. MELD was better in predicting survival in a stepwise Cox model but both scores were equally predictive in c statistics for one month, three month, and one year survival. Renal function was the strongest independent predictor of survival.
CONCLUSIONS: Although MELD was the primary predictor of overall survival in multivariate analysis, c statistics showed that both scores can be used for patients undergoing TIPS with equal accuracy. For assessing prognosis in patients undergoing TIPS implantation, there seems little reason to replace the well established Child-Pugh score.

Entities:  

Mesh:

Year:  2003        PMID: 12740346      PMCID: PMC1773665          DOI: 10.1136/gut.52.6.879

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  46 in total

1.  Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients.

Authors:  J M LaBerge; K A Somberg; J R Lake; R L Gordon; R K Kerlan; N L Ascher; J P Roberts; M M Simor; C A Doherty; J Hahn
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

2.  Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients.

Authors:  J M LaBerge; E J Ring; R L Gordon; J R Lake; M M Doherty; K A Somberg; J P Roberts; N L Ascher
Journal:  Radiology       Date:  1993-05       Impact factor: 11.105

3.  Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.

Authors:  I Albers; H Hartmann; J Bircher; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

4.  Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.

Authors:  C Merkel; M Bolognesi; S Bellon; S Bianco; B Honisch; H Lampe; P Angeli; A Gatta
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

5.  Critical appraisal of the angiographic portacaval shunt (TIPS).

Authors:  W S Helton; A Belshaw; S Althaus; S Park; D Coldwell; K Johansen
Journal:  Am J Surg       Date:  1993-05       Impact factor: 2.565

6.  Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.

Authors:  E Christensen; P Schlichting; L Fauerholdt; C Gluud; P K Andersen; E Juhl; H Poulsen; N Tygstrup
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics.

Authors:  A Abad-Lacruz; E Cabré; F González-Huix; F Fernández-Bañares; M Esteve; R Planas; J M Llovet; J C Quer; M A Gassull
Journal:  Am J Gastroenterol       Date:  1993-03       Impact factor: 10.864

8.  Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis.

Authors:  A Arrigoni; T Gindro; G Aimo; N Cappello; A Meloni; P Benedetti; G P Molino; G Verme; M Rizzetto
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

9.  The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.

Authors:  M Rössle; K Haag; A Ochs; M Sellinger; G Nöldge; J M Perarnau; E Berger; U Blum; A Gabelmann; K Hauenstein
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

10.  Assessment of the validity of the INR system for patients with liver impairment.

Authors:  M J Kovacs; A Wong; K MacKinnon; K Weir; M Keeney; E Boyle; M Cruickshank
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

View more
  69 in total

1.  TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.

Authors:  Alexander S Rosemurgy; Emmanuel E Zervos; Whalen C Clark; Donald P Thometz; Thomas J Black; Bruce R Zwiebel; Bruce T Kudryk; L Shane Grundy; Larry C Carey
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

2.  Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension.

Authors:  Mubin I Syed; Hetal Karsan; Hector Ferral; Azim Shaikh; Uzma Waheed; Talal Akhter; Alan Gabbard; Kamal Morar; Robert Tyrrell
Journal:  World J Hepatol       Date:  2012-02-27

3.  Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.

Authors:  Edward Wolfgang Lee; Andrew Kuei; Sammy Saab; Ronald W Busuttil; Francisco Durazo; Steven-Huy Han; Mohamed M El-Kabany; Justin P McWilliams; Stephen T Kee
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.

Authors:  Jennifer Guy; Ma Somsouk; Stephen Shiboski; Robert Kerlan; John M Inadomi; Scott W Biggins
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-26       Impact factor: 11.382

5.  Transjugular intrahepatic portosystemic shunt-related complications and practical solutions.

Authors:  Renato Ripamonti; Hector Ferral; Marc Alonzo; Nilesh H Patel
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

6.  Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.

Authors:  Michael J Wallace; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

7.  Transjugular intrahepatic portosystemic shunt in the management of refractory ascites.

Authors:  Guadalupe Garcia-Tsao
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

8.  Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy.

Authors:  Toru Mizuguchi; Tadashi Katsuramaki; Takayuki Nobuoka; Masaki Kawamoto; Hideki Oshima; Hiroyuki Kawasaki; Hitoshi Kikuchi; Chihiro Shibata; Koichi Hirata
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 9.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.

Authors:  Wen-Sheng Tzeng; Reng-Hong Wu; Ching-Yih Lin; Jyh-Jou Chen; Ming-Juen Sheu; Lok-Beng Koay; Chuan Lee
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.